MYCN and neuroblastoma: For instance, Campbell et al. retrospectively analyzed data from 4,672 patients with NB and found that the patients with MYCN amplification had a 25.1% complete induction response rate compared with 12.4% for patients with MYCN wild-type tumors (22).